Nombre del producto:6,7-Dihydro-2H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3(5H)-one

IUPAC Name:3,4-diazatricyclo[9.4.0.0²,⁷]pentadeca-1(15),2,6,11,13-pentaen-5-one

CAS:25823-52-3
Fórmula molecular:C13H12N2O
Pureza:95%
Número de catálogo:CM324062
Peso molecular:212.25

Unidad de embalaje Stock disponible Precio($) Cantidad
CM324062-250mg in stock Ʀȁư
CM324062-1g 1-2 Weeks ȬNJư

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :25823-52-3
Fórmula molecular:C13H12N2O
Punto de fusión:-
Código de sonrisas:O=C1C=C(CCCC2=CC=CC=C23)C3=NN1
Densidad:
Número de catálogo:CM324062
Peso molecular:212.25
Punto de ebullición:
Nº Mdl:MFCD16871353
Almacenamiento:

Column Infos

Bemcentinib
Bemcentinib is a potentially first-in-class selective AXL inhibitor in development for STK11 mutated NSCLC and severe respiratory infections. Extensive studies confirm the ability to combine bemcentinib with immune checkpoint inhibitors, chemotherapies and targeted therapies with the goal of improving a patient’s immune response and delaying the development of chemoresistance. Bemcentinib is currently being investigated in combination with immune checkpoint inhibition and chemotherapy in first line NSCLC patients harboring mutations in the STK11 gene, a known prognostic factor of poor response to existing therapies.

Related Products